Wolverine Trading, LLC T2 Biosystems, Inc. Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.09 - $565.0 $906 - $5.69 Million	10,072 New	10,072 $1,000
Q3 2021 Nov 12, 2021	SELL	$0.86 - $1.21 $6,853 - $9,642	-7,969 Reduced 28.31%	20,179 $18,000
Q2 2021 Aug 06, 2021	BUY	$1.04 - $1.69 $15,349 - $24,942	14,759 Added 110.23%	28,148 $35,000
Q1 2021 May 14, 2021	SELL	$1.32 - $3.79 $12,389 - $35,572	-9,386 Reduced 41.21%	13,389 $21,000
Q2 2019 Aug 20, 2019	SELL	$1.47 - $3.16 $6,285 - $13,512	-4,276 Reduced 15.81%	22,775 $38,000
Q1 2019 May 15, 2019	BUY	$2.56 - $4.48 $8,079 - $14,138	3,156 Added 13.21%	27,051 $71,000
Q4 2018 Feb 14, 2019	BUY	$2.98 - $6.86 $32,923 - $75,789	11,048 Added 86.0%	23,895 $71,000
Q3 2018 Nov 14, 2018	SELL	$5.36 - $7.83 $3,591 - $5,246	-670 Reduced 4.96%	12,847 $96,000
Q1 2018 May 15, 2018	BUY	$4.21 - $7.0 $13,884 - $23,086	3,298 Added 32.27%	13,517 $88,000
Q4 2017 Feb 14, 2018	SELL	$3.73 - $4.6 $11,454 - $14,126	-3,071 Reduced 23.11%	10,219 $42,000
Q3 2017 Nov 15, 2017	BUY	$3.9 - $6.78 $51,831 - $90,106	13,290	13,290 $56,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.